ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prior, T.
Right arrow Articles by Bankson, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prior, T.
Right arrow Articles by Bankson, D.
Annals of Clinical and Laboratory Science, Vol 19, Issue 2, 107-113
Copyright © 1989 by Association of Clinical Scientists


Articles

Sensitivity of serum fructosamine in short term glycemic control

TW Prior, JF Chapman, and DD Bankson

The serum fructosamine concentrations measured in 64 diabetic patients correlated (r = 0.73) with glycated hemoglobins (HbA1c). However, 23 percent of the diabetic patients had normal fructosamine and abnormal HbA1c levels. In order to determine whether or not the discrepant values were the result of recent glycemic regulation by the diabetic patient, fructosamine levels of patients suffering from diabetic ketoacidosis (along with beta-hydroxybutyrate levels) were closely monitored. It was shown that short term alterations (one to three days) in serum glucose did not significantly affect fructosamine levels. Therefore, disagreements between fructosamine and HbA1c are most likely due to longer term improvement in glucose control by the diabetic or the result of the higher imprecision of the HbA1c assay.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the Association of Clinical Scientists.